XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona to Present at the 39th Annual J.P. Morgan Healthcare Conference

Dentsply Sirona to Present at the 39th Annual J.P. Morgan Healthcare Conference

CHARLOTTE, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced it will participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th.

Don Casey, Chief Executive Officer, will represent the company. He is scheduled to present at 7:30AM Eastern Time. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting . A replay of the presentation will also be available on the Dentsply Sirona website at .

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 132-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information

Investors:

John P. Sweeney

VP, Investor Relations





EN
07/01/2021

Underlying

XRAYDENTSPLY SIRONA Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business F...

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company CHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has completed the evaluation of strategic alternatives for its Wellspect Healthcare business (“Wellspect”), which was announced in February 2025. As a part of its review process, Dentsply Si...

10h / 22m 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona to Participate in Upcoming Investor Conferences

Dentsply Sirona to Participate in Upcoming Investor Conferences CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 2:35 pm ETBaird Global Healthcare Conference on September 9, 2025, at 1:25 pm ET Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About ...

August 26, 2025 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona Reports Second Quarter 2025 Results

Dentsply Sirona Reports Second Quarter 2025 Results Net sales of $936 million decreased (4.9%), decreased (6.7%) in constant currency including a (3.2%) Byte sales impactGAAP gross margin of 52.4%, GAAP net loss per share of ($0.22)Adjusted gross margin of 55.9%, adjusted EBITDA margin of 21.1%, adjusted EPS of $0.52Executed $550 million debt offeringReaffirmed FY25 outlookLeadership transition with Dan Scavilla appointed CEO effective August 1, 2025 and Matt Garth appointed CFO effective May 30, 2025 CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Si...

August 7, 2025 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a current member of the Board of Directors of Dentsply Sirona (the “Board”), has been appointed President and Chief Executive Officer, effective A...

July 21, 2025 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

Dentsply Sirona to Host Second Quarter Conference Call on August 7th CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s website at prior to t...

July 10, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch